Richard Powers wanders Berlin and reflects on what fiction can tell us about history @ Design Observer. If I knew, even roughly, how Berlin died, I would lay out the facts in a chain of evidence. And if I had a theory, however tenuous, about the city’s post-mortem life, I would argue it straight up: major premise, minor premise, conclusion. As it is, even the rough arc of exposition, rising action, climax, and denouement feels a bit shaky at best. But I can tell you how it feels, in July, on a sunny day late in the month, at the end of my twelve-week stay in the world’s strangest city.I’m in Berlin for one reason: to explore how fact and fiction might profitably be collided together. I’ve been in town since early spring, teaching a seminar on that topic at the Freie Universität, with two dozen students from all over Germany who were born knowing more about the topic than I can ever presume to teach them.
The course is an experiment, probably not a great thing to try while a guest in a foreign country. But I’ve always wanted to explore, in a classroom, how factual argument and fictive projection, set side by side, might triangulate into places that neither can reach alone. Shaw may be right that “The sign of a truly educated person is to be deeply moved by statistics.” But natural selection has shaped us to be moved mainly by things on our own private scale. Discursive argument models and projects, producing tremendous leverage, but without a hook that hits us where we live, facts rarely compel us to change our lives. Narrative imagination can twist our guts and shatter our souls, but it’s mired in local fates that must be small enough to look familiar.Suppose, though, that you yoked the two together. Thought and feeling, argument and stories, statistical analysis and good old twists of the viscera: these two inimical modes, played off of one another, might produce a kind of deep parallax, tricking the mind’s eye into turning those two skewed planes into the illusion of three dimensions. I’ve come to Berlin to test the idea in a live clinical trial.